Surgery – Instruments – Orthopedic instrumentation
Reexamination Certificate
2008-06-25
2011-12-13
Gamett, Daniel C (Department: 1647)
Surgery
Instruments
Orthopedic instrumentation
C606S053000, C424S484000, C424S486000, C514S008800
Reexamination Certificate
active
08075562
ABSTRACT:
Controlled release of biopharmaceutical growth factors from a hydroxyapatite coating on a bioresorbable interference screw used in cruciate ligament reconstruction surgery on a human. Biologically active scaffolds, such as interference bone screws used for ligament fixation, made by growing calcium phosphate-based hydroxyapatite coatings on bioresorbable poly(α-hydroxy ester) scaffolds that provide controlled mineral dissolution and controlled release of bone morphogenetic protein-2. The biologically active scaffold provides improved bioavailability of BMP-2 growth factor that in turn provides enhanced graft-bone healing in the tibial bone tunnel. The coating method uses surface hydrolysis and modified simulated body fluid incubation which does not require solvent or heat and is conducted at room temperature.
REFERENCES:
patent: 4889917 (1989-12-01), Tanihara et al.
patent: 4894442 (1990-01-01), Toyama et al.
patent: 5132402 (1992-07-01), Tanihara et al.
patent: 5171837 (1992-12-01), Tanihara et al.
patent: 5344654 (1994-09-01), Rueger et al.
patent: 5624900 (1997-04-01), Suda et al.
patent: 5658592 (1997-08-01), Tanihara et al.
patent: 5770229 (1998-06-01), Tanihara et al.
patent: 5880216 (1999-03-01), Tanihara et al.
patent: 5980883 (1999-11-01), Tanihara et al.
patent: 6162864 (2000-12-01), Tanihara et al.
patent: 6187742 (2001-02-01), Wozney et al.
patent: 6541022 (2003-04-01), Murphy et al.
patent: 6617307 (2003-09-01), Nishimura et al.
patent: 6767928 (2004-07-01), Murphy et al.
patent: 6916321 (2005-07-01), TenHuisen et al.
patent: 7049293 (2006-05-01), Nishimura et al.
patent: 7132397 (2006-11-01), Katsuura et al.
patent: 7132506 (2006-11-01), Nishimura et al.
patent: 7179795 (2007-02-01), Wiederanders et al.
patent: 7229441 (2007-06-01), Trieu et al.
patent: 2002/0061837 (2002-05-01), Lough et al.
patent: 2003/0007971 (2003-01-01), Tanihara et al.
patent: 2003/0162941 (2003-08-01), Tanihara et al.
patent: 2005/0079470 (2005-04-01), Rutherford et al.
patent: 2006/0235204 (2006-10-01), Desjarlais et al.
patent: 2007/0026437 (2007-02-01), Wang et al.
Yan Lu, M.D., et al., “Comparison of Single- Versus Double-Tunnel Tendon-to-Bone Healing in an Ovine Model A Biochemical and Histological Analysis,” Am. J. Sports Med. 37:512-517 (2009).
Yan Lu, M.D., et al., “Influence of Hydroxyapatite-Coated and Growth Factor-Releasing Interference Screws on Tendon-Bone Healing in an Ovine Model,” Arthroscopy 25(12):1427-1435 (2009).
Anderson K et al., “Augmentation of Tendon Healing in an Intraarticular Bone Tunnel with Use of a Bone Growth Factor,” Am J Sports Med 2001, 29:689-698.
Buelow Ju et al., “A New Biocortical Tibial Fixation Technique in Anterior Cruciate Ligament Reconstruction with Quadruple Hamstring Graft,” Knee Surg Sports Traumatol Arthrosc 2000, 8:218-225.
Harris H et al., “Functional analysis of bone sialoprotein: identification of the hydroxyapatite-nucleating and cell-binding domains by recombinant peptide expression and site-directed mutagenesis,” Bone 2000, 27:795-802.
Hoang Q et al., “Bone Recognition Mechanism of Porcine Osteocalcin form Crystal Structure,” Nature 2003, 425:977-980.
Huq, N.L. et al., “The amino acid sequences of goat, pig and wallaby osteocalcins,” Biochem. Int., 1984, 8(4):521-527.
Knowledge Enterprise, “The worldwide orthopedic market,” The Institute for Orthopedic Enlightenment, Chagrin Falls, OH, 2003:1-60.
Lind M, “Growth Factor Stimulation of Bone Healing: Effects on osteoblasts, osteomies and implants fixation,” Acta Orthop Scand Suppl 1998, 283:2-37.
Linn RM et al., “Achilles Tendon Allograft Reconstruction of Anterior Cruciate Ligament Deficient Knee,” Am J Sports Med 1993, 21:825-831.
Medtech Insight, “Poor man's growth factors: do they work?,” Medtech Insight Newletter, Nov./Dec. 2003:263-264.
Murphy WL et al, “Sustained Release of Vascular Endothelial Growth Factor From Mineralized poly(lactide-co-glycolide) Scaffolds for Tissue Engineering,” Biomaterials 2000, 21:2521-2527.
Murphy WL et al, “Bioinspired Growth of Crystalline Carbonate Apatite on Biodegradable Polymer Substrata,” J Am Chem Soc 2002, 124-1910-1917.
Murphy WL et al, “Bone Regeneration via a Mineral Substrate and Induced Angiogenesis,” J Dent Res 2004, 83:204-210.
Murphy WL et al, “Effects of a bone-like mineral film on phenotype of adult human mesenchymal stem cells in vitro,” Biomaterials 2005, 26:303-310.
Rodeo SA et al., “Use of Recombinant Human Bone Morphogenetic Protein-2 to Enhance Tendon Healing in a Bone Tunnel,” Am J Sports Med 1999, 27:476-488.
Saito A et al., “Activation of osteo-progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope,” Biochimica et Biophysica Acta 2003, 1651:60-67.
Saito A et al., “Prolonged ectopic calcification induced by BMP-2-derived synthetic peptide,” Journal of biomedical materials research. Part A 2004, 701:115-121.
Seeherman H, “The Influence of Delivery Vehicles and Their Properties on the Repair of Segmental Defects and Fractures with Osteogenic Factors,” J Bone Joint Surg Am 2001, 83A Suppl. 1:S79-81.
Sheridan M et al., Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery,: J. Cvontrol Release 2000, 64:94-102.
Tye C et al., “Dilineation of the hydroxyapatite-nucleating domains of bone sialoprotein,” J. Biol. Chem. 2003, 278:7949-7955.
Winn S et al., “Sustained Release Emphasizing Recombinant Human Bone Morphogenetic Protein-2,” Adv Drug Deliv Rev 1998, 31:303-318.
Graf Ben K.
Lee Jae-Sam
Markel Mark D.
Murphy William L.
Armstrong Teasdale LLP
Gamett Daniel C
Wisconsin Alumni Research Foundation
LandOfFree
Controlled release of biopharmaceutical growth factors from... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release of biopharmaceutical growth factors from..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release of biopharmaceutical growth factors from... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4308163